vs
ALEXANDERS INC（ALX）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ALEXANDERS INC的1.4倍（$75.5M vs $53.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -4.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.9%）
亚历山大公司是一家房地产投资信托企业，在纽约大都会区持有七处物业，包括彭博有限合伙企业总部所在地列克星敦大道731号。该公司由乔治·法卡斯和路易斯·施瓦德伦于1928年创立，目前由沃那多房产信托控股。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ALX vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$53.3M
营收增速更快
PBYI
高出32.5%
-4.7%
两年增速更快
PBYI
近两年复合增速
-6.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.3M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | — | — |
| 营收同比 | -4.7% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.75 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALXPBYI
| Q4 25 | $53.3M | $75.5M | ||
| Q3 25 | $53.4M | $54.5M | ||
| Q2 25 | $51.6M | $52.4M | ||
| Q1 25 | $54.9M | $46.0M | ||
| Q4 24 | $55.9M | $59.1M | ||
| Q3 24 | $55.7M | $80.5M | ||
| Q2 24 | $53.4M | $47.1M | ||
| Q1 24 | $61.4M | $43.8M |
净利润ALXPBYI
| Q4 25 | — | — | ||
| Q3 25 | $6.0M | $8.8M | ||
| Q2 25 | $6.1M | $5.9M | ||
| Q1 25 | $12.3M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.7M | $20.3M | ||
| Q2 24 | $8.4M | $-4.5M | ||
| Q1 24 | $16.1M | $-4.8M |
毛利率ALXPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ALXPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率ALXPBYI
| Q4 25 | — | — | ||
| Q3 25 | 11.2% | 16.2% | ||
| Q2 25 | 11.9% | 11.2% | ||
| Q1 25 | 22.4% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 12.0% | 25.2% | ||
| Q2 24 | 15.7% | -9.6% | ||
| Q1 24 | 26.2% | -11.0% |
每股收益（稀释后）ALXPBYI
| Q4 25 | $0.75 | $0.26 | ||
| Q3 25 | $1.16 | $0.17 | ||
| Q2 25 | $1.19 | $0.12 | ||
| Q1 25 | $2.40 | $0.06 | ||
| Q4 24 | $2.39 | $0.40 | ||
| Q3 24 | $1.30 | $0.41 | ||
| Q2 24 | $1.63 | $-0.09 | ||
| Q1 24 | $3.14 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $128.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $109.2M | $130.3M |
| 总资产 | $1.1B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ALXPBYI
| Q4 25 | $128.2M | $97.5M | ||
| Q3 25 | $286.1M | $94.4M | ||
| Q2 25 | $313.0M | $96.0M | ||
| Q1 25 | $319.9M | $93.2M | ||
| Q4 24 | $338.5M | $101.0M | ||
| Q3 24 | $354.8M | $96.7M | ||
| Q2 24 | $410.9M | $96.8M | ||
| Q1 24 | $526.3M | $107.2M |
总债务ALXPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ALXPBYI
| Q4 25 | $109.2M | $130.3M | ||
| Q3 25 | $128.3M | $115.3M | ||
| Q2 25 | $145.4M | $104.7M | ||
| Q1 25 | $163.1M | $97.1M | ||
| Q4 24 | $176.9M | $92.1M | ||
| Q3 24 | $190.7M | $71.1M | ||
| Q2 24 | $212.5M | $48.5M | ||
| Q1 24 | $230.1M | $51.0M |
总资产ALXPBYI
| Q4 25 | $1.1B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.3B | $194.9M | ||
| Q1 25 | $1.3B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.4B | $220.7M | ||
| Q2 24 | $1.5B | $205.0M | ||
| Q1 24 | $1.4B | $214.1M |
负债/权益比ALXPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ALXPBYI
| Q4 25 | $73.4M | $14.4M | ||
| Q3 25 | $-9.3M | $9.7M | ||
| Q2 25 | $43.6M | $14.1M | ||
| Q1 25 | $15.7M | $3.6M | ||
| Q4 24 | $54.1M | $15.6M | ||
| Q3 24 | $-5.0M | $11.0M | ||
| Q2 24 | $11.5M | $1.0M | ||
| Q1 24 | $16.8M | $11.2M |
自由现金流ALXPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ALXPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ALXPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ALXPBYI
| Q4 25 | — | — | ||
| Q3 25 | -1.55× | 1.10× | ||
| Q2 25 | 7.12× | 2.41× | ||
| Q1 25 | 1.28× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.75× | 0.54× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
